Nature of the Business and Basis of Presentation (Details) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended						9 Months Ended
	Oct. 22, 2021	Nov. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Sep. 30, 2021 USD ($) shares	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($) shares
Subsidiary, Sale of Stock [Line Items]
Redeemable convertible preferred stock, shares issued upon conversion | shares			19,185,183						19,185,183		11,788,435
Net loss			$ 14,430	$ 9,901	$ 8,380	$ 6,990	$ 6,174	$ 4,686	$ 32,711	$ 17,850
Accumulated deficit			75,222						75,222		$ 42,511
Cash and cash equivalents			$ 122,172						$ 122,172		$ 39,045
Subsequent event
Subsidiary, Sale of Stock [Line Items]
Reverse stock split ratio	0.1382
IPO | Subsequent event
Subsidiary, Sale of Stock [Line Items]
Aggregate shares issued and sold | shares		10,436,250
Stock price | $ / shares		$ 20.00
Gross proceeds from issuance of common stock		$ 208,700
Net proceeds from issuance of common stock		$ 190,900
Redeemable convertible preferred stock, shares issued upon conversion | shares		19,185,183
Over-Allotment Option | Subsequent event
Subsidiary, Sale of Stock [Line Items]
Shares issued | shares		1,361,250